Indication

Trochanteric Bursitis

1 clinical trial

1 product

Clinical trial

Study to Assess the Safety and Efficacy of FX006 Administered to Patients With Greater Trochanteric Bursitis

Status: Completed, Estimated PCD: 2022-12-14

Product